Literature DB >> 21418129

Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.

Alfredo Guglielmi1, Andrea Ruzzenente, Tommaso Campagnaro, Silvia Pachera, Simone Conci, Alessandro Valdegamberi, Marco Sandri, Calogero Iacono.   

Abstract

BACKGROUND: Lymph node (LN) metastases are a major negative prognostic factor for peri-hilar cholangiocarcinoma (PCC). Prognostic significance of the extent of LN dissection, number of metastatic LN and the lymph node ratio (LNR) are still under debate. AIMS: The aims of the present study were to evaluate the prognostic value of the LN status, the total number of LNs evaluated and LNR in PCC.
METHODS: Between 1990 and 2008, 62 patients with PCC submitted to surgical resection with curative intent were retrospectively evaluated. Number and status of harvested LN were recorded.
RESULTS: In 53 patients (85.4%) regional lymphadenectomy was performed. Median number of LNs examined was 7 (range 1-25). Median survival was 41.9 months in patients with N0 compared with 22.7 months in 21 patients (39.6%) with N+ (P= 0.03). Median survival was 3, 18.5 and 29 months for patients with 0, 1-3 and >3 LN retrieved, respectively (P < 0.01). Five-year survival for patients above and below the LNR cut-off value of 0.25 was 0% and 22.5%, respectively (P= 0.03).
CONCLUSIONS: LN metastases are a major prognostic factor for survival after surgical resection of PCC. The number of LN harvested and LNR showed high prognostic value.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21418129      PMCID: PMC3081624          DOI: 10.1111/j.1477-2574.2010.00277.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  20 in total

1.  Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds.

Authors:  Alastair L Young; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-28       Impact factor: 7.027

2.  Proximal bile duct cancer: high resectability rate and 5-year survival.

Authors:  B Launois; J Terblanche; M Lakehal; J M Catheline; E Bardaxoglou; S Landen; J P Campion; F Sutherland; B Meunier
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  Surgical strategies for carcinoma of the hepatic duct confluence.

Authors:  Y Ogura; Y Kawarada
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

4.  Extended resections for hilar cholangiocarcinoma.

Authors:  P Neuhaus; S Jonas; W O Bechstein; R Lohmann; C Radke; N Kling; C Wex; H Lobeck; R Hintze
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

5.  TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system.

Authors:  Hideki Nishio; Masato Nagino; Koji Oda; Tomoki Ebata; Toshiyuki Arai; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-07-07       Impact factor: 3.445

6.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

8.  Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.

Authors:  S Iwatsuki; S Todo; J W Marsh; J R Madariaga; R G Lee; I Dvorchik; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

9.  Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.

Authors:  Takukazu Nagakawa; Masato Kayahara; Seiyo Ikeda; Shunji Futakawa; Akira Kakita; Hirofumi Kawarada; Masaki Matsuno; Tadahiro Takada; Ken Takasaki; Hiroshi Tanimura; Seiki Tashiro; Yoshio Yamaoka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

10.  Worldwide trends in mortality from biliary tract malignancies.

Authors:  Tushar Patel
Journal:  BMC Cancer       Date:  2002-05-03       Impact factor: 4.430

View more
  24 in total

1.  Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.

Authors:  Traian Dumitrascu; Dragos Chirita; Mihnea Ionescu; Irinel Popescu
Journal:  J Gastrointest Surg       Date:  2013-01-15       Impact factor: 3.452

Review 2.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

3.  Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution.

Authors:  Francesca Ratti; Federica Cipriani; Riccardo Ariotti; Annalisa Gagliano; Michele Paganelli; Marco Catena; Luca Aldrighetti
Journal:  Surg Endosc       Date:  2015-07-21       Impact factor: 4.584

4.  Adjuvant treatment in biliary tract cancer: to treat or not to treat?

Authors:  Stefano Cereda; Carmen Belli; Michele Reni
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

5.  Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Alessandro Valdegamberi; Fabio Bagante; Francesca Bertuzzo; Simone Conci; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2013-09-19       Impact factor: 3.452

6.  Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Francesca Bertuzzo; Calogero Iacono
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

7.  Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Authors:  Kai Mao; Jieqiong Liu; Jian Sun; Jianlong Zhang; Jie Chen; Timothy M Pawlik; Lisa K Jacobs; Zhiyu Xiao; Jie Wang
Journal:  J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 4.029

8.  Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.

Authors:  Kosin Wirasorn; Thundon Ngamprasertchai; Jarin Chindaprasirt; Aumkhae Sookprasert; Narong Khantikaew; Ake Pakkhem; Piti Ungarereevittaya
Journal:  World J Gastrointest Oncol       Date:  2013-04-15

9.  The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

Authors:  Byoung Hyuck Kim; Kyubo Kim; Eui Kyu Chie; Jeanny Kwon; Jin-Young Jang; Sun Whe Kim; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Journal:  J Gastrointest Surg       Date:  2015-08-04       Impact factor: 3.452

Review 10.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.